Adaptive Biotechnologies (NASDAQ:ADPT) Issues Earnings Results

Adaptive Biotechnologies (NASDAQ:ADPT – Get Rating) released its earnings results on Wednesday. The company reported ($0.40) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.34) by ($0.06), Briefing.com reports. The firm had revenue of $37.65 million during the quarter, compared to analyst estimates of $36.81 million. Adaptive Biotechnologies had a negative return […]

Related Keywords

Canada ,Chad ,R Mark Adams ,Harlan Robins ,Stacyl Taylor ,Credit Suisse Group ,Morgan Stanley ,Adaptive Biotechnologies Company Profile ,Adaptive Biotechnologies Corp ,Vident Investment Advisory ,Scotiabank ,Securities Exchange Commission ,Royal Bank ,Adaptive Biotechnologies ,Get Rating ,Exchange Commission ,Mark Adams ,Investment Advisory ,Suisse Group ,Chad Robins ,Chris Carlson ,Adaptive Biotechnologies Daily ,Nasdaq Adpt ,Adpt ,Medical ,Earnings ,